Clinical Trial Update: Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind trial is evaluating whether semaglutide improves neurological outcomes after endovascular thrombectomy in patients with acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: RenJi Hospital | Conditions: Acute Ischemic Stroke | Phase 3 | Status: NOT_YET_RECRUITING